Kuehn Law, PLLC is investigating whether certain officers and directors of Arcus Biosciences, Inc. breached their fiduciary duties through potential self-dealing. The investigation could lead to shareholder damages and corporate governance reforms. Long-term shareholders are encouraged to contact the law firm to protect their rights, as there may be limited time to act. The firm offers free consultation and covers all case costs for investors.
More than a decade ago, Fundstrat advised clients to allocate just 2% of their portfolios to Bitcoin, which has since grown to represent over 85% of those portfolios due to Bitcoin's massive price appreciation. Despite most investors still lacking an...
Pump.fun (PUMP) saw a significant price rally driven by a $40.83 million increase in Open Interest, mainly from long positions in the perpetual market. Whale investors played a key role, with high buying activity reflected in a positive Whale Retail ...
The S&P 500 showed strength by rallying even after a high Consumer Price Index (CPI) report and strong expectations of a Federal Reserve rate hike. This suggests that investor sentiment remains bullish despite inflation concerns and potential tighten...
The iShares MSCI South Korea ETF (EWY) has surged 147.83% over the past year, led by heavy exposure to Samsung and SK hynix, which benefit from strong demand for AI-related memory chips. Nearly half of EWY's holdings are concentrated in these two com...
Airbnb CEO Brian Chesky declared AI the best thing to happen to the company, citing an 80% increase in software shipping and AI handling nearly 45% of customer service tickets. In Q2 2026, Airbnb reported a 16.5% revenue rise to $3.6 billion and a 27...
